# Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients?

> **NCT01002534** · PHASE2 · TERMINATED · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 5 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Vardenafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01002534
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2012-06
- **Final completion:** 2018-03
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** not yet started
- **Last updated:** 2019-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01002534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01002534, "Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients?". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01002534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*